Let us introduce PROMPPT.

Click play on the video below.

Improving outcomes for patients using opioid medicines for persistent non-cancer pain

Proactive clinical Review of patients taking Opioid Medicines long-term for persistent Pain led by clinical Pharmacists in primary care Teams


Why are we doing this research?

Persistent pain affects up to half the UK adult population and 10- 14% (around 8 million adults) say the pain causes moderate or severe interference with their life.

What does the research involve?

PROMPPT is a 5-year research programme and launched in March 2019.
Year 1 started with the Q-PROMPPT study that aimed to find out about patients, clinical pharmacists and GPs’ experiences and views.

First pain management reviews completed

As part of our feasibility study, the first PROMPPT pain management reviews have been attended by patients living with persistent pain. The pain management reviews are being delivered remotely by clinical pharmacists working from the patients’ GP practices. The aim of the review is to…